Home » Business, Health & Medicine, Pharmaceuticals & Biotech, Science, UK » Bipolar Disorder Market Forecast Report to 2024 includes Risk Factors, Comorbidities, and Global Trends
“EpiCast Report Bipolar Disorder – Epidemiology Forecast to 2024”
The Bipolar EpiCast Report provides an overview of the risk factors, comorbidities, and global trends for bipolar spectrum disorder in the eight major markets (8MM) (US, France, Germany, Italy, Spain, UK, Japan, and Canada).

Bipolar disorder, also known as bipolar depression or manic depression, is a psychological disorder that presents with severe shifts in mood from one extreme to another. The mood swings occur in a cyclic or periodic pattern that includes feelings of emotional highs (mania or hypomania) and lows (depression). In between episodes of mood swings, patients typically return to their regular state of being. During a manic or depressive episode, the disease can be debilitating, severely affecting a person’s ability to perform on the job or maintain good relationships with other people.

In 2014, there were 13,808,283 12-month and 23,140,488 lifetime total prevalent cases of bipolar disorder in the 8MM. In 2014, of the lifetime total prevalent cases, 52.15% were cyclothymic disorder, 24.58% bipolar I, and 23.27% bipolar II. Publisher epidemiologists forecast that there will be approximately 14,703,622 12-month and 24,616,577 lifetime total prevalent cases of bipolar disorder in 2024.

Complete Report Available at: http://www.reportsweb.com/EpiCast-Report:-Bipolar-Disorder—Epidemiology-Forecast-to-2024

Scope

– The Bipolar EpiCast Report provides an overview of the risk factors, comorbidities, and global trends for bipolar spectrum disorder in the eight major markets (8MM) (US, France, Germany, Italy, Spain, UK, Japan, and Canada). It includes a 10-year epidemiological forecast for both 12-month and lifetime total prevalent cases of bipolar I, bipolar II, and cyclothymic disorder segmented by sex and age in these markets.

– The bipolar epidemiology report is written and developed by Masters- and PhD-level epidemiologists.

– The EpiCast Report is in-depth, high quality, transparent and market-driven, providing expert analysis of disease trends in the 8MM.

Reasons to buy

The Bipolar EpiCast report will allow you to –

– Develop business strategies by understanding the trends shaping and driving the global bipolar market.

– Quantify patient populations in the global bipolar market to improve product design, pricing, and launch plans.

– Organize sales and marketing efforts by identifying the sex and age groups that present the best opportunities for bipolar therapeutics in each of the markets covered.

– Identify the subtype of bipolar disorder spectrum most important to your market plans.

Purchase this Report at: http://www.reportsweb.com/buy&RW0001178658/buy/3995

Table of Contents:

1 Table of Contents

1.1 List of Tables

1.2 List of Figures

2 Introduction

2.1 Catalyst

2.2 Related Reports

2.3 Upcoming Related Reports

3 Epidemiology

3.1 Disease Background

3.2 Risk Factors and Comorbidities

3.3 Global Trends

3.4 Forecast Methodology

3.5 Epidemiological Forecast of Bipolar Disorder (2014-2024)

3.6 Discussion

4 Appendix

4.1 Bibliography

4.2 Physicians and Specialists Included in this Study

4.3 About the Authors

4.4 About Publisher

4.5 About EpiCast

4.6 Disclaimer


Get Sample Report at:
http://www.reportsweb.com/inquiry&RW0001178658/sample

Media Contact
Company Name: ReportsWeb
Contact Person: Rajat Sahni
Email: sales@reportsweb.com
Phone: +1-646-491-9876
Country: United States
Website: http://www.reportsweb.com/EpiCast-Report:-Bipolar-Disorder—Epidemiology-Forecast-to-2024

Comments are closed.